These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21389148)

  • 1. Antibody responses to a spore carbohydrate antigen as a marker of nonfatal inhalation anthrax in rhesus macaques.
    Saile E; Boons GJ; Buskas T; Carlson RW; Kannenberg EL; Barr JR; Boyer AE; Gallegos-Candela M; Quinn CP
    Clin Vaccine Immunol; 2011 May; 18(5):743-8. PubMed ID: 21389148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium.
    Mehta AS; Saile E; Zhong W; Buskas T; Carlson R; Kannenberg E; Reed Y; Quinn CP; Boons GJ
    Chemistry; 2006 Dec; 12(36):9136-49. PubMed ID: 17133642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores.
    Kuehn A; Kovác P; Saksena R; Bannert N; Klee SR; Ranisch H; Grunow R
    Clin Vaccine Immunol; 2009 Dec; 16(12):1728-37. PubMed ID: 19793896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.
    Clement KH; Rudge TL; Mayfield HJ; Carlton LA; Hester A; Niemuth NA; Sabourin CL; Brys AM; Quinn CP
    Clin Vaccine Immunol; 2010 Nov; 17(11):1753-62. PubMed ID: 20739500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component.
    Kubler-Kielb J; Vinogradov E; Hu H; Leppla SH; Robbins JB; Schneerson R
    Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8709-12. PubMed ID: 18562275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-detection of anthrose containing tetrasaccharide in the exosporium of Bacillus anthracis and Bacillus cereus strains.
    Tamborrini M; Oberli MA; Werz DB; Schürch N; Frey J; Seeberger PH; Pluschke G
    J Appl Microbiol; 2009 May; 106(5):1618-28. PubMed ID: 19226390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
    Cybulski RJ; Sanz P; McDaniel D; Darnell S; Bull RL; O'Brien AD
    Vaccine; 2008 Sep; 26(38):4927-39. PubMed ID: 18657585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent evolution of diverse Bacillus anthracis outbreak strains toward altered surface oligosaccharides that modulate anthrax pathogenesis.
    Norris MH; Kirpich A; Bluhm AP; Zincke D; Hadfield T; Ponciano JM; Blackburn JK
    PLoS Biol; 2020 Dec; 18(12):e3001052. PubMed ID: 33370274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
    BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium.
    Daubenspeck JM; Zeng H; Chen P; Dong S; Steichen CT; Krishna NR; Pritchard DG; Turnbough CL
    J Biol Chem; 2004 Jul; 279(30):30945-53. PubMed ID: 15152001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore Persistence.
    Wang Y; Jenkins SA; Gu C; Shree A; Martinez-Moczygemba M; Herold J; Botto M; Wetsel RA; Xu Y
    PLoS Pathog; 2016 Jun; 12(6):e1005678. PubMed ID: 27304426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
    Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
    Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
    Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
    Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against
    Majumder S; Das S; Somani VK; Makam SS; Kingston JJ; Bhatnagar R
    Front Immunol; 2019; 10():498. PubMed ID: 30941133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
    J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
    Dumas EK; Demiraslan H; Ingram RJ; Sparks RM; Muns E; Zamora A; Larabee J; Garman L; Ballard JD; Boons GJ; James JA; Kayabas U; Doganay M; Farris AD
    PLoS One; 2020; 15(4):e0230782. PubMed ID: 32294093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.